Prejunctional muscarinic inhibitory control of acetylcholine release in the human isolated detrusor: involvement of the M4 receptor subtype
- 1 February 2000
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 129 (3), 493-500
- https://doi.org/10.1038/sj.bjp.0703080
Abstract
1. Experiments were carried out in human detrusor strips to characterize muscarinic receptor subtypes involved in the prejunctional regulation of acetylcholine (ACh) release from cholinergic nerve terminals, and in the postjunctional smooth muscle contractile response. 2. In detrusor strips preincubated with [3H]-choline, electrical field stimulation (600 pulses) delivered in six trains at 10 Hz produced a tritium outflow and a contractile response. In the presence of 10 microM paraoxon (to prevent ACh degradation) the tritium outflow was characterized by HPLC analysis as [3H]-ACh (76%) and [3H]-choline (24%). 3. Electrically-evoked [3H]-ACh release was abolished by tetrodotoxin (TTX: 300 nM) and unaffected by hexamethonium (10 microM), indicating a postganglionic event. It was reduced by physostigmine (100 nM) and the muscarinic receptor agonist, muscarone (10 nM-1 microM), and enhanced by atropine (0.1-100 nM). These findings indicate the presence of a muscarinic negative feedback mechanism controlling ACh release. 4. The effects of various subtype-preferring muscarinic receptor antagonists were evaluated on [3H]-ACh release and muscle contraction. The rank potency (-log EC50) orders at pre- and postjunctional level were: atropine > or = 4-diphenyl-acetoxy-N-piperidine (4-DAMP) > mamba toxin 3 (MT-3) > tripitramine > para-fluorohexahydrosiladiphenidol (pF-HHSiD) > or = methoctramine > or = pirenzepine > tripinamide, and atropine > or = 4-DAMP > pF-HHSiD >> pirenzepine = tripitramine > tripinamide > methoctramine >> MT-3, respectively. 5. The comparison of pre- and post-junctional potencies and the relationship analysis with the affinity constants at human cloned muscarinic receptor subtypes indicates that the muscarinic autoreceptor inhibiting ACh release in human detrusor is an M4 receptor, while the receptor involved in muscular contraction belongs to the M3 subtype.Keywords
This publication has 35 references indexed in Scilit:
- Universal Template Approach to Drug Design: Polyamines as Selective Muscarinic Receptor AntagonistsJournal of Medicinal Chemistry, 1998
- Tolterodine – a new bladder-selective antimuscarinic agentEuropean Journal of Pharmacology, 1997
- Presynaptic inhibitory muscarinic autoreceptors modulating 3H-acetylcholine release in human isolated detrusor muscleLife Sciences, 1997
- Muscarinic receptor subtype selective toxinsLife Sciences, 1997
- Evaluation of mRNAs Encoding Muscarinic Receptor Subtypes in Human Detrusor MuscleJournal of Urology, 1996
- Muscarinic Cholinergic Receptor Subtypes in Human Detrusor Muscle Studied by Labeled and Nonlabeled Pirenzepine, AFDX-116 and 4DAMPUrologia Internationalis, 1995
- A toxin from the green mamba Dendroaspis angusticeps: Amino acid sequence and selectivity for muscarinic m4 receptorsFEBS Letters, 1994
- Binding profile of the selective muscarinic receptor antagonist tripitramineEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Characterization of prejunctional muscarinic autoreceptors in the rat urinary bladderLife Sciences, 1993
- Antimuscarinic activity of telenzepine on isolated human urinary bladder: No role for m1-muscarinic receptorsGeneral Pharmacology: The Vascular System, 1992